<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02431091</url>
  </required_header>
  <id_info>
    <org_study_id>CHUSTP-OCTHIV</org_study_id>
    <nct_id>NCT02431091</nct_id>
  </id_info>
  <brief_title>Evaluation of the Role of OCT in the Detection of HIV-associated Neurocognitive Disorder</brief_title>
  <acronym>OCT-HIV</acronym>
  <official_title>Evaluation of the Role of Optical Coherence Tomography (OCT) in the Detection of HIV-associated Neurocognitive Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Saint Pierre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fonds iris-Recherche, Fondation Roi Baudouin, Belgium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Saint Pierre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the sensitivity and specificity of the use of
      optical coherence tomography to detect HIV-associated neurocognitive disorder compared to MRI
      and usual cognitive screening tools.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2015</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with abnormal OCT (retinal thickness in µm) in patients with abnormal full neurocognitive evaluation</measure>
    <time_frame>Baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with abnormal neuroscreen and/or modified dementia scale in patients with abnoraml full neurocognitve evaluation</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between retinal thickness (in µm) and cerebral atrophy in % of brain parenchymal fraction ( measured by cerebral MRI)</measure>
    <time_frame>Baseline</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>AIDS-Related Dementia Complex</condition>
  <arm_group>
    <arm_group_label>Definite Case</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with abnormal response on both the screening questions and at least one of the cognitive screening tests.
Optical Coherence Tomography is performed in all definite cases</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with abnormal response on the screening questions but normal cognitive screening tests Optical Coherence Tomography is performed in matched control B patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with normal response on both the screening questions and all the cognitive screening tests.
Optical Coherence Tomography is performed in matched control A patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>Optical Coherence Tomography provides a non invasive evaluation of the thickness of different layers of the retina</description>
    <arm_group_label>Definite Case</arm_group_label>
    <arm_group_label>Control B</arm_group_label>
    <arm_group_label>Control A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  HIV infection

          -  Antiretroviral treatment

          -  Undetectable plasmatic HIV viral load (viral load&lt;50 copies/ml) for at least 6 months

          -  Ability to understand and give approved consent

        Exclusion Criteria:

          -  Any present or past ophthalmologic illness that may impair OCT results

          -  Previous cerebral infection with sequel

          -  Previous cerebrovascular disease with sequel

          -  Severe psychiatric illness

          -  Active alcohol or drug abuse

          -  Active chronic hepatitis C

          -  Inability to perform french cognitive assessment

          -  Inability to perform a MRI

          -  Inability to perform a lumbar puncture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stéphane Dewit, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CHU St Pierre, Service des Maladies Infectieuses</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Agnes Libois, MD</last_name>
    <phone>+3225355008</phone>
    <email>agnes_libois@stpierre-bru.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hopital St Pierre</name>
      <address>
        <city>Brussels</city>
        <zip>1000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 22, 2015</study_first_submitted>
  <study_first_submitted_qc>April 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2015</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Saint Pierre</investigator_affiliation>
    <investigator_full_name>Agnès Libois</investigator_full_name>
    <investigator_title>Chef de Clinique Adjoint</investigator_title>
  </responsible_party>
  <keyword>Optical Coherence Tomography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
    <mesh_term>Neurocognitive Disorders</mesh_term>
    <mesh_term>AIDS Dementia Complex</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

